Instil Bio, Inc.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $2.2M | — | $2.2M | — | — | — | $2.2M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $5.1M | — | $5.3M | — | — | — | $5.9M |
| Operating Income | — | $-5.6M | — | $-7.0M | — | — | — | $-15.0M |
| Operating Margin | — | -248.9% | — | -312.7% | — | — | — | -670.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-4.3M | — | $-4.2M | — | — | — | $-13.6M |
| Net Margin | — | -191.7% | — | -187.5% | — | — | — | -606.0% |
| EPS (Basic) | — | $-0.63 | — | $-0.62 | — | — | — | $-2.01 |
| EPS (Diluted) | — | $-0.63 | — | $-0.62 | — | — | — | $-2.01 |
| Shares Outstanding (Basic) | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M |
| Shares Outstanding (Diluted) | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M | 6.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |